TITLE

Hormonal treatment for endometriosis associated pelvic pain

AUTHOR(S)
Wu Shun Felix Wong; Chi Eung Danforn Lim
PUB. DATE
July 2011
SOURCE
Iranian Journal of Reproductive Medicine;Summer2011, Vol. 9 Issue 3, p163
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background: Endometriosis is a common gynecological problem associated with chronic pelvic pain. Objective: To evaluate the effectiveness of current hormonal treatments of endometriosis associated pain. Materials and Methods: Randomized Controlled studies identified from databases of Medline and Cochrane Systemic Review groups were pooled. 7 RCTs were recruited for evaluation in this review. Data from these studies were pooled and meta-analysis was performed in three comparison groups: 1) Progestogen versus GnRHa; 2) Implanon versus Progestogen (injection); 3) Combined oral contraceptive pills versus placebo and progestogen. Response to treatment was measured as a reduction in pain score. Pain improvement was defined as improvement ⩾1 at the end of treatment. Results: There was no significant difference between treatment groups of progestogen and GnRHa (RR: 0.036; CI:-0.030-0.102) for relieving endometriosis associated pelvic pain. Long acting progestogen (Implanon) and Mirena are not inferior to GnRHa and depot medroxy progesterone acetate (DMPA) (RR: 0.006; CI:-0.142-0.162). Combined oral contraceptive pills demonstrated effective treatment of relieving endometriosis associated pelvic pain when compared with placebo groups (RR:0.321CI-0.066-0.707). Progestogen was more effective than combined oral contraceptive pills in controlling dysmenorrhea (RR:-0.160; CI:-0.386-0.066), however, progestogen is associated with more side effects like spotting and bloating than the combined contraceptive pills. Conclusion: Combined oral contraceptive pills (COCP), GnRHa and progestogens are equally effective in relieving endometriosis associated pelvic pain. COCP and progestogens are relatively cheap and more suitable for long-term use as compared to GnRHa. Long-term RCT of medicated contraceptive devices like Mirena and Implanon are required to evaluate their long-term effects on relieving the endometriosis associated pelvic pain.
ACCESSION #
69849520

 

Related Articles

  • Mirena Intra-Uterine System: Does it Improve Long Term Symptoms in Women with Chronic Pelvic Pain and/or Endometriosis after Laparo- scopy? A Multicentre Randomized Controlled Trial. Alhamdan, Dalya; Bignardi, Tommaso; Hardas, George; Merkur, Harry; Condous, George // Reviews on Recent Clinical Trials;Sep2010, Vol. 5 Issue 3, p143 

    Background: Chronic pelvic pain (CPP) is a complex clinical scenario, which affects 15% of women. The published literature lacks a consistent definition of CPP. However according to Vercillini et al., CPP is defined by the duration and type of pelvic pain. CPP is present if the pelvic pain...

  • Menopausal hormone therapy and risk of ovarian cancer: systematic review and meta-analysis. Claudia M. Greiser; Eberhard M. Greiser; Martina Dören // Human Reproduction Update;Sep2007, Vol. 13 Issue 5, p453 

    Knowledge about the impact of menopausal hormone therapy (MHT) on the risk of ovarian cancer (OvC) is insufficient, and studies are inconsistent. Mortality from OvC ranks highest among cancer sites in female reproductive organs. We performed meta-analyses to assess the impact of specified types...

  • Changing Concepts: Menopausal Hormone Therapy and Breast Cancer. Chlebowski, Rowan T.; Anderson, Garnet L. // JNCI: Journal of the National Cancer Institute;Apr2012, Vol. 104 Issue 7, p517 

    Hormone therapy is still used by millions of women for menopausal symptoms. Concerns regarding hormone therapy and breast cancer were initially based on case reports and retrospective case–control studies. However, recent results from large prospective cohort studies and the...

  • Hormone replacement therapy and prevention of vertebral fractures: a meta-analysis of randomised trials. Torgerson, David J.; Bell-Syer, Sally EM.; Torgerson, D J; Bell-Syer, S E // BMC Musculoskeletal Disorders;2001, Vol. 2, p7 

    Background: Hormone replacement therapy (HRT) is often seen as the treatment of choice for preventing fractures in women. We undertook a recent meta-analysis of randomised trials which suggested that HRT reduced non-vertebral fractures by 30%. In this analysis we extend that...

  • Meta-analysis Finds Little Evidence of Increased Side Effects in Women Using Phytoestrogens. O'Mathúna, Dónal P. // Alternative Medicine Alert;Dec2009, Vol. 12 Issue 12, p133 

    WOMEN WHO EXPERIENCE VARIOUS NEGATIVE SYMPTOMS DURING menopause commonly turn to phytoestrogens in the hope finding relief. Phytoestrogen use has become more widespread since concerns were raised about the adverse effects associated with hormone replacement therapy. However, concerns have also...

  • Oral HRT doubles venous thromboembolism risk.  // Reactions Weekly;6/7/2008, Issue 1205, p4 

    The article reports on the results of a meta-analysis which indicate that using oral hormone replacement therapy (HRT) more than doubles the risk of venous thromboembolism. Researchers considered data from eight observational studies and nine randomised controlled trials for the meta-analysis....

  • TRADITIONAL CHINESE MEDICINE COMBINED WITH HORMONE THERAPY TO TREAT PREMATURE OVARIAN FAILURE: A META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS. Mei-Jing Kou; Xiu-Fang Ding; Jia-Xu Chen; Yan Liu; Yue-Yun Liu // African Journal of Traditional, Complementary & Alternative Medi;2016, Vol. 13 Issue 5, p160 

    Background: This meta-analysis aimed to provide critically estimated evidence for the advantages and disadvantages of Chinese herbal medicines used for premature ovarian failure (POF), which could provide suggestions for rational treatments. Materials and Methods: The databases searched included...

  • Antidepressant drugs for chronic urological pelvic pain: an evidence-based review. Papandreou, Christos; Skapinakis, Petros; Giannakis, Dimitrios; Sofikitis, Nikolaos; Mavreas, Venetsanos // Advances in Urology;2009, Special section p1 

    The use of antidepressant drugs for the management of chronic pelvic pain has been supported in the past. This study aimed to evaluate the available evidence for the efficacy and acceptability of antidepressant drugs in the management of urological chronic pelvic pain. Studies were selected...

  • Weighing progestin's role in HRT. D.R.M. // Cortlandt Forum;2/25/96, Vol. 9 Issue 2, p80 

    Discusses the safety of using progestin in hormone replacement therapy for preventing endometrial cancer. Increase in breast cancer risk; Effects of unopposed estrogen.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics